Serotonin: A regulator of neuronal morphology and circuitry

Trends in Neurosciences

Volumn 33, Issue 9, 2010, Pages 424-434

  Daubert, Elizabeth A ^a   Condron, Barry G ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SEROTONIN;

AUTOREGULATION; BEHAVIOR; BRAIN DEVELOPMENT; DOWN SYNDROME; INVERTEBRATE; NERVE CELL PLASTICITY; NEUROPSYCHIATRY; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SEROTONINERGIC SYSTEM; VERTEBRATE;

ANIMALS; CENTRAL NERVOUS SYSTEM; HUMANS; NERVE NET; NERVOUS SYSTEM DISEASES; NEURONS; RECEPTORS, SEROTONIN; SEROTONIN;

EID: 77956009908     PISSN: 01662236     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tins.2010.05.005     Document Type: Review

References (112)

1. Serfaty C.A., et al. Nutritional tryptophan restriction and the role of serotonin in development and plasticity of central visual connections. Neuroimmunomodulation 2008, 15:170-175.
2. Papaioannou A., et al. Effects of neonatal handling on basal and stress-induced monoamine levels in the male and female brain. Neuroscience 2002, 114:195-206.
3. Winter C., et al. Prenatal immune activation leads to multiple changes in basal neurotransmitter levels in the adult brain: implications for brain disorders of neurodevelopmental origin such as schizophrenia. Int. J. Neuropsychopharmacol. 2009, 12:513-524.
4. Holmes A. Genetic variation in cortico-amygdala serotonin function and risk for stress-related disease. Neurosci. Biobehav. Rev. 2008, 32:1293-1314.
5. Xu Y., et al. Selective serotonin reuptake inhibitor disrupts organization of thalamocortical somatosensory barrels during development. Brain Res. Dev. Brain Res. 2004, 150:151-161.
6. Sykes P.A., Condron B.G. Development and sensitivity to serotonin of Drosophila serotonergic varicosities in the central nervous system. Dev. Biol. 2005, 286:207-216.
7. Chen J., Condron B.G. Branch architecture of the fly larval abdominal serotonergic neurons. Dev. Biol. 2008, 320:30-38.
8. Bunin M.A., Wightman M.W. Quantitative evaluation of 5-hydroxytryptamine (serotonin) neuronal release and uptake: an investigation of extrasynaptic transmission. J. Neurosci. 1998, 18:4854-4860.
9. Nichols D.E., Nichols C.D. Serotonin receptors. Chem Rev. 2008, 108:1614-1641.
10. Erickson J.T., et al. Arrest of 5-HT neuron differentiation delays respiratory maturation and impair neonatal homeostatic responses to environmental challenges. Respir. Physiol. Neurobiol. 2007, 159:85-101.
11. Hodges M.R., et al. Transgenic mice lacking serotonin neurons have severe apnea and high mortality during development. J. Neurosci. 2009, 29:10341-10349.
12. Alenina N., et al. Growth retardation and altered autonomic control in mice lacking brain serotonin. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:10332-10337.
13. Sze J.Y., et al. Food and metabolic signaling defects in a Caenorhabditis elegans serotonin-synthesis mutant. Nature 2000, 403:560-564.
14. Savelieva K.V., et al. Genetic disruption of both tryptophan hydroxylase genes dramatically reduces serotonin and affects behavior in models sensitive to antidepressants. PLoS One 2008, 3:e3301.
15. Nebigil C.G., et al. Serotonin 2B receptor is required for heart development. Proc. Natl. Acad. Sci. U. S. A. 2000, 97:9508-9513.
16. Levin M., et al. Of minds and embryos: left-right asymmetry and the serotonergic controls of pre-neural morphogenesis. Dev. Neurosci. 2006, 28:171-185.
17. Scott M.M., Deneris E.S. Making and breaking serotonin neurons and autism. Int. J. Dev. Neurosci. 2005, 23:277-285.
18. Levitt P., Rakic P. The time of genesis, embryonic origin and differentiation of the brain stem monoamine neurons in the rhesus monkey. Brain Res. 1982, 256:35-57.
19. Hawthorne A.L., et al. Serotonergic neurons migrate radially through the neuroepithelium by dynamin-mediated somal translocation. J. Neurosci. 2010, 30:420-430.
20. Acklin S.E., Nicholls J.G. Intrinsic and extrinsic factors influencing properties and growth patterns of identified leech neurons in culture. J. Neurosci. 1990, 10:1082-1090.
21. Donovan S.L., et al. GAP-43 is critical for normal development of the serotonergic innervation in forebrain. J. Neurosci. 2002, 22:3543-3552.
22. Katori S., et al. Protocadherin-alpha family is required for serotonergic projections to appropriately innervate target brain areas. J. Neurosci. 2009, 29:9137-9147.
23. 1A receptors releases the serotonergic growth factor, protein S100, and alters astroglial morphology. Brain Res. 1990, 528:155-158.
24. Nishiyama H., et al. Normal development of serotonergic neurons in mice lacking S100B. Neurosci. Lett. 2002, 321:49-52.
25. Brüning G., et al. Prenatal development of the serotonin transporter in mouse brain. Cell Tissue Res. 1997, 289:211-221.
26. Couch J.A., et al. robo2 and robo3 interact with eagle to regulate serotonergic neuron differentiation. Development 2004, 131:997-1006.
27. Gutknecht L. Deficiency of brain 5-HT synthesis but serotonergic neuron formation in Tph2 knockout mice. J. Neural Transm. 2008, 115:1127-1132.
28. Chen J., Condron B.G. Drosophila serotonergic varicosities are not distributed in a regular manner. J. Comp. Neurol. 2009, 515:441-453.
29. Diefenbach T.J., et al. Neurite branch development of an identified serotonergic neuron from embryonic Helisoma: evidence for autoregulation by serotonin. Dev. Biol. 1995, 167:282-293.
30. Budnik V., et al. Altered branching of serotonin-containing neurons in Drosophila mutants unable to synthesize serotonin and dopamine. J. Neurosci. 1989, 9:2866-2877.
31. Koert C.E., et al. Functional implications of neurotransmitter expression during axonal regeneration: serotonin, but not peptides, auto-regulate axon growth of an identified central neuron. J. Neurosci. 2001, 21:5597-5606.
32. Shemer A.V., et al. Dose-related effects of prenatal 5-methoxytryptamine (5-MT) on development of serotonin terminal density and behavior. Brain Res. Dev. Brain Res. 1991, 59:59-63.
33. Whitaker-Azmitia P.M., Azmitia E.C. Autoregulation of fetal serotonergic neuronal development: role of high affinity serotonin receptors. Neurosci. Lett. 1986, 67:307-312.
34. Ramamoorthy S., Blakely R.D Phosphorylation and sequestration of serotonin transporters differentially modulated by psychostimulants. Science 1999, 285:763-766.
35. Ase A.R., et al. Regional changes in density of serotonin transporter in the brain of 5-HT1A and 5-HT1B knockout mice, and of serotonin innervation in the 5-HT1B knockout. J. Neurochem. 2001, 78:619-630.
36. Lehmann K. Serotonin fibre densities in subcortical areas: differential effects of isolated rearing and methamphetamine. Brain Res. Dev. Brain. Res. 2003, 147:143-152.
37. Lidov H.G.W., Molliver M.E. An immunohistochemical study of serotonin neuron development in the rat: ascending pathways and terminal fields. Brain Res. Bull. 1982, 8:389-430.
38. Lambe E.K., et al. Differential postnatal development of catecholamine and serotonin inputs to identified neurons in prefrontal cortex of rhesus monkey. J. Neurosci. 2000, 20:8780-8787.
39. Altamura C., et al. Altered neocortical cell density and layer thickness in serotonin transporter knockout mice: a quantitation study. Cereb. Cortex 2007, 17:1394-1401.
40. Heils A., et al. Allelic variation of human serotonin transporter gene expression. J. Neurochem. 1996, 66:2621-2624.
41. Canli T., et al. Beyond affect: a role for genetic variation of the serotonin transporter in neural activation during a cognitive attention task. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:12224-12229.
42. Frodl T., et al. Reduced gray matter brain volumes are associated with variants of the serotonin transporter gene in major depression. Mol. Psychiatry 2008, 13:1093-1101.
43. Gaspar P., et al. The developmental role of serotonin: news from mouse molecular genetics. Nat. Rev. Neurosci. 2003, 4:1002-1012.
44. Esaki T., et al. Developmental disruption of serotonin transporter function impairs cerebral responses to whisker stimulation in mice. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:5582-5587.
45. Persico A.M., et al. Barrel pattern formation requires serotonin uptake by thalamocortical afferents, and not vesicular monoamine release. J. Neurosci. 2001, 21:6862-6873.
46. Vitalis T., et al. Embryonic depletion of serotonin affects cortical development. Eur. J. Neurosci. 2007, 26:331-344.
47. Bonnin A., et al. Serotonin modulates the response of embryonic thalamocortical axons to netrin-1. Nat. Neurosci. 2007, 10:588-597.
48. Riccio O., et al. Excess of serotonin affects embryonic interneuron migration through activation of the serotonin receptor 6. Mol. Psychiatry 2009, 14:280-290.
49. Brezun J.M., Daszuta A. Serotonin depletion in the adult rat produces differential changes in highly polysialylated form of neural cell adhesion molecule and tenascin-C immunoreactivity. J. Neurosci. Res. 1999, 55:54-70.
50. Hendricks T.J., et al. Pet-1 ETS gene plays a critical role in 5-HT neuron development and is required for normal anxiety-like and aggressive behavior. Neuron 2003, 37:233-247.
51. Bou-Flores C., et al. Abnormal phrenic motoneuron activity and morphology in neonatal monoamine oxidase A-deficient transgenic mice: Possible role of a serotonin excess. J. Neurosci. 2000, 20:4646-4656.
52. Lerch-Haner J.K., et al. Serotonergic transcriptional programming determines maternal behavior and offspring survival. Nat. Neurosci. 2008, 11:1001-1003.
53. Caspi A., et al. Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science 2003, 301:386-389.
54. Holmes A., et al. Abnormal behavioral phenotypes of serotonin transporter knockout mice: parallels with human anxiety and depression. Biol. Psychiatry 2003, 54:953-959.
55. Chen K., et al. A spontaneous point mutation produces monoamine oxidase A/B knock-out mice with greatly elevated monoamines and anxiety-like behavior. J. Biol. Chem. 2004, 279:39645-39652.
56. 1A receptor acts during development to establish normal anxiety-like behavior in the adult. Nature 2002, 416:396-400.
57. 2+/calmodulin-dependent protein kinase II contributes to the developmental programming of anxiety in serotonin receptor 1A knock-out mice. J. Neurosci. 2008, 28:6250-6257.
58. Ansorge M.S., et al. Early-life blockade of the 5-HT transporter alters emotional behavior in adult mice. Science 2004, 306:879-881.
59. Popa D., et al. Lasting syndrome of depression produced by reduction in serotonin uptake during postnatal development: evidence from sleep, stress and behavior. J. Neurosci. 2008, 28:3546-3554.
60. Alexandre C., et al. Early life blockade of 5-hydroxytryptamine 1A receptors normalizes sleep and depression-like behavior in adult knock-out mice lacking the serotonin transporter. J. Neurosci. 2006, 26:5554-5564.
61. Norcross M., et al. Effects of adolescent fluoxetine treatment on fear-, anxiety- or stress-related behaviors in C57BL/6J or BALB/cJ mice. Psychopharmacology 2008, 200:413-424.
62. Wellman C.L., et al. Impaired stress-coping and fear extinction and abnormal corticolimbic morphology in serotonin transporter knock-out mice. J. Neurosci. 2007, 27:684-691.
63. Richardson-Jones J.W., et al. 5-HT1A autoreceptor levels determine vulnerability to stress and response to antidepressants. Neuron 2010, 65:40-52.
64. Whittle N., et al. Fetal Down syndrome brains exhibit aberrant levels of neurotransmitters critical for normal brain development. Pediatrics 2007, 120:e1465-e1471.
65. Seidl R., et al. Serotonin (5-HT) in brains of adult patients with Down syndrome. J. Neural Transm. Suppl. 1999, 57:221-232.
66. Geldmacher D.S., et al. Treatment of functional decline in adults with Down syndrome using selective serotonin-reuptake inhibitor drugs. J. Geriatr. Psychiatry Neurol. 1997, 10:99-104.
67. McDougle C.J., et al. Neurochemistry in the pathophysiology of autism. J. Clin. Psychiatry 2005, 66(Suppl. 10):9-18.
68. Croonenberghs J., et al. Central serotonergic hypofunction in autism: results of the 5-hydroxy-tryptophan challenge test. Neuroendocrinol. Lett. 2007, 28:449-455.
69. Makkonen I., et al. Serotonin and dopamine transporter binding in children with autism determined by SPECT. Dev. Med. Child Neurol. 2008, 50:593-597.
70. Chugani D.C., et al. Developmental changes in brain serotonin synthesis capacity in autistic and nonautistic children. Ann. Neurol. 1999, 45:287-295.
71. Chananda S.R., et al. Significance of abnormalities in developmental trajectory and asymmetry of cortical serotonin synthesis in autism. Int. J. Dev. Neurosci. 2005, 23:171-182.
72. Whitaker-Azmitia P.M. Serotonin and brain development: role in human developmental diseases. Brain Res. Bull. 2001, 56:479-485.
73. McNamara I.M., et al. Further studies in the developmental hyperserotonemia model (DHS) of autism: social, behavioral and peptide changes. Brain Res. 2008, 1189:203-214.
74. Boylan C.B., et al. Modeling early cortical serotonergic deficits in autism. Behav Brain Res. 2007, 176:94-108.
75. van Luijtelaar M.G., et al. Similarities between aberrant serotonergic fibers in the aged and 5,7-DHT denervated young adult rat brain. Exp. Brain Res. 1989, 78:81-89.
76. Ueda S., et al. Chronic treatment with melatonin attenuates serotonergic degeneration in the striatum and olfactory tubercle of Zitter mutant rats. Neurosci. Lett. 2008, 448:212-216.
77. Aucoin J.S., et al. Selective cholinergic denervation, independent from oxidative stress, in a mouse model of Alzheimer's disease. Neuroscience 2005, 132:73-86.
78. Liu Y., et al. Amyloid pathology is associated with progressive monoaminergic neurodegeneration in a transgenic mouse model of Alzheimer's disease. J. Neurosci. 2008, 28:13805-13814.
79. Azmitia E.C., Nixon R. Dystrophic serotonergic axons in neurodegenerative diseases. Brain Res. 2008, 1217:185-194.
80. Green A.R., et al. The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy'). Pharmacol. Rev. 2003, 55:463-508.
81. Kosofsky B.E., Molliver M.E. The serotonergic innervation of cerebral cortex: different classes of axon terminals arise from dorsal and medial raphe nuclei. Synapse 1987, 1:153-168.
82. O'Hearn E., et al. Methylenedioxyamphetamine (MDA) and methylenedioxymethamphetamine (MDMA) cause selective ablation of serotonergic axon terminals in forebrain: immunocytochemical evidence for neurotoxicity. J. Neurosci. 1988, 8:2788-2803.
83. Meyer J.S., et al. Development and characterization of a novel animal model of intermittent MDMA ('ecstasy') exposure during adolescence. Ann. N.Y. Acad. Sci. 2008, 1139:151-163.
84. Thomasius R., et al. Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users. Psychopharmacology (Berl) 2003, 167:85-96.
85. Molliver M.E., et al. Neurotoxicity of MDMA and related compounds: anatomic studies. Ann. N.Y. Acad. Sci. 1990, 600:649-664.
86. Appel N.M., et al. Fenfluramine selectively and differentially decreases the density of serotonergic nerve terminals in rat brain: evidence from immunocytochemical studies. J. Pharmacol. Exp. Ther. 1989, 249:928-943.
87. Daubert E.A., et al. Serotonergic dystrophy induced by excess serotonin. Mol. Cell. Neurosci. 2010, 44:297-306.
88. Rudnick G., Wall S.C. The molecular mechanism of 'ecstasy' [3,4-methylenedioxymethamphetamine (MDMA)]: serotonin transporters are targets for MDMA-induced serotonin release. Proc. Natl. Acad. Sci. U. S. A. 1992, 89:1817-1821.
89. Schuldiner S. Amphetamine derivatives interact with both plasma membrane and secretory vesicle biogenic amine transporters. Mol. Pharmocol. 1993, 44:1227-1231.
90. Udo H., et al. Serotonin-induced regulation of the actin network for learning-related synaptic growth requires Cdc42, N-WASP, and PAK in Aplysia sensory neurons. Neuron 2005, 45:887-901.
91. Dasari S., Cooper R.L. Modulation of sensory-CNS-motor circuits by serotonin, octopamine, and dopamine in semi-intact Drosophila larva. Neurosci. Res. 2004, 48:221-227.
92. Hughes C.L., Thomas J.B. A sensory feedback circuit coordinates muscle activity in Drosophila. Mol. Cell. Neurosci. 2007, 35:383-396.
93. Borue X., et al. Quantitative evaluation of serotonin release and clearance in Drosophila. J. Neurosci. Methods 2009, 179:300-308.
94. Borue X., et al. Both synthesis and reuptake are critical for replenishing the releasable serotonin pool in Drosophila. J. Neurochem. 2010, 113:188-199.
95. Scott M.M., et al. A genetic approach to access serotonin neurons for in vivo and in vitro studies. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:16472-16477.
96. Lillesaar C., et al. Axonal projections originating from raphe serotonergic neurons in the developing and adult zebrafish, Danio rerio, using transgenics to visualize raphe-specific pet1 expression. J. Comp. Neurol. 2009, 512:158-182.
97. Benzekhroufa K., et al. Adenoviral vectors for highly selective gene expression in central serotonergic neurons reveal quantal characteristics of serotonin release in the rat brain. BMC Biotechnol. 2009, 19:23. doi:10.1186/1472-6750-9-23.
98. Benzekhroufa K., et al. Targeting central serotonergic neurons with lentiviral vectors based on a transcriptional amplification strategy. Gene Therapy 2009, 16:681-688.
99. Wylie C.J., et al. Distinct transcriptomes define rostral and caudal serotonin neurons. J. Neurosci. 2010, 30:670-684.
100. Abrams J.K., et al. Anatomic and functional topography of the dorsal raphe nucleus. Ann. N. Y. Acad. Sci. 2004, 1018:46-57.
101. Dai J.X., et al. Enhanced contextual fear memory in central serotonin-deficient mice. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:11981-11986.
102. Simon A.F., et al. Drosophila vesicular monoamine transporter mutants can adapt to reduced or eliminated vesicular stores of dopamine and serotonin. Genetics 2009, 181:525-541.
103. Fon E.A., et al. Vesicular transport regulates monoamine storage and release but is not essential for amphetamine action. Neuron 1997, 19:1271-1283.
104. Fukui M., et al. Vmat2 heterozygous mutant mice display a depressive-like phenotype. J. Neurosci. 2007, 27:10520-10529.
105. Mapara S., et al. Identification, molecular structure and expression of two cloned serotonin receptors from the pond snail, Helisoma trivolvis. J. Exp. Biol. 2008, 211:900-910.
106. Price C.J., Goldberg J.I. Serotonin activation of a cyclic AMP-dependent sodium current in an identified neuron from Helisoma trivolvis. J. Neurosci. 1993, 13:4979-4987.
107. Polak K.A., et al. A novel calmodulin antagonist, CGS 9343B, modulates calcium-dependent changes in neurite outgrowth and growth cone movements. J. Neurosci. 1991, 11:534-542.
108. Zhou F.Q., Cohan C.S. Growth cone collapse through coincident loss of actin bundles and leading edge actin without actin depolymerization. J. Cell Biol. 2001, 153:1071-1084.
109. Torreano P.J., et al. The effects of collapsing factors on F-actin content and microtubule distribution of Helisoma growth cones. Cell Motil. Cytoskeleton 2005, 60:166-179.
110. Walther D.J., et al. Serotonylation of small GTPases is a signal transduction pathway that triggers platelet α-granule release. Cell 2003, 115:851-862.
111. Paulmann N., et al. Intracellular serotonin modulates insulin secretion from pancreatic β-cells by protein serotonylation. PLoS Biol. 2009, 7:e1000229.
112. 2A receptor stimulation. J. Pharmacol. Exp. Ther. 2008, 326:153-162.